Vascular Biogenics Stock Technical Analysis

VBLTDelisted Stock  USD 0.16  0.01  5.88%   
As of the 18th of April 2024, Vascular Biogenics has the Variance of 39.44, coefficient of variation of (911.16), and Risk Adjusted Performance of (0.06). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vascular Biogenics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate thirteen technical drivers for Vascular Biogenics, which can be compared to its competition. Please validate Vascular Biogenics market risk adjusted performance and treynor ratio to decide if Vascular Biogenics is priced more or less accurately, providing market reflects its prevalent price of 0.16 per share. As Vascular Biogenics appears to be a penny stock we also recommend to double-check its jensen alpha numbers.

Vascular Biogenics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vascular, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Vascular
  
Vascular Biogenics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Vascular Biogenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Vascular Biogenics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vascular Biogenics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Vascular Biogenics Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Vascular Biogenics Trend Analysis

Use this graph to draw trend lines for Vascular Biogenics. You can use it to identify possible trend reversals for Vascular Biogenics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vascular Biogenics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Vascular Biogenics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Vascular Biogenics applied against its price change over selected period. The best fit line has a slop of   0.0011  , which may suggest that Vascular Biogenics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.04, which is the sum of squared deviations for the predicted Vascular Biogenics price change compared to its average price change.

About Vascular Biogenics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vascular Biogenics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vascular Biogenics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vascular Biogenics price pattern first instead of the macroeconomic environment surrounding Vascular Biogenics. By analyzing Vascular Biogenics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vascular Biogenics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vascular Biogenics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Vascular Biogenics April 18, 2024 Technical Indicators

Most technical analysis of Vascular help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vascular from various momentum indicators to cycle indicators. When you analyze Vascular charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Vascular Stock

If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk